Warning letter
Continental Manufacturing Chemist, Inc.: warning letter of Dec 20, 2017
FDA warning letter 532514 · Detroit District Office
Key facts
| Reference number | 532514 |
|---|---|
| Company | Continental Manufacturing Chemist, Inc. |
| Subject | CGMP/Drug Products/Adulterated |
| Issue date | Dec 20, 2017 |
| Posted date | Jan 9, 2018 |
| Issuing office | Detroit District Office |
| Product type | Drugs |
| CFR sections cited | 211.194(a), 211.192, 211.22(a), 211.42(c) |
| Inspection city | Madrid |
| Inspection ZIP | 50156 |
| Inspection start date | Apr 24, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: